Dickinson, Craig Duane,Driver, David Albert,Darling, Ryan James,Gonciarz, Malgorzata Donata,Micanovic, Radmila
申请号：
AU2012318956
公开号：
AU2012318956A1
申请日:
2012.09.25
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21), pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, or metabolic syndrome, or any combination thereof, using such variants.
